Medicare drug price negotiations: A game-changer for seniors’ healthcare
By
Luka Yancopoulos
Nov 02, 2023
The relatively recent passage of the Inflation Reduction Act, which among other provisions, allows Medicare to negotiate prescription drug prices, marks a monumental shift in senior healthcare in America.
All participants exceeded twofold increase in spike-specific IgG, with a geometric mean fold risk of 19.5 on day 57.
FDA approves updated Novavax COVID-19 vaccine
Oct 04, 2023
The updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus.
Women have higher risk for solicited reactions after flu shot
Sep 29, 2023
Women have a higher risk for injection site reactions, systemic reactions and severe reactions.
Flu vaccine uptake varies by sociodemographic factors in CKD patients
Sep 26, 2023
Just under three-quarters of patients with chronic kidney disease receive flu vaccines
‘Unprecedented’ season sees vaccines for all three viruses affecting seniors
By
Kimberly Bonvissuto
Sep 26, 2023
The nation is entering an “unprecedented vaccine season,” with the availability of vaccines for three viruses responsible for the most hospitalizations among older adults, according to Omnicare pharmacists.
For the first time, vaccines are available for all 3 viruses targeting older adults
By
Kimberly Bonvissuto
Sep 20, 2023
COVID-19 and respiratory syncytial virus cases are increasing, and the height of influenza season is on the horizon, but older adults and long-term care staff members are entering the first virus season...
Immune response not inferior with coadministration of COVID-19, flu shots
Sep 14, 2023
A similar immune response and no increase in the rate of reactogenicity events was seen with coadministration versus administering the COVID-19 vaccine alone.
FDA advisers say next round of COVID-19 booster shots should target an XBB Variant
Jun 15, 2023
Protection against the original strain of the virus will be dropped from the updated vaccines as it could contribute to lower vaccine efficacy against newer strains.
FDA approves Pfizer RSV vaccine for older adults
Jun 01, 2023
The CDC is expected to meet later in the month to adopt vaccine recommendations for older Americans.